Pages that link to "Q34581578"
Jump to navigation
Jump to search
The following pages link to Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis (Q34581578):
Displaying 50 items.
- The Wonders of Phosphodiesterase-5 Inhibitors: A Majestic History (Q26741387) (← links)
- A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction (Q26749094) (← links)
- Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis (Q26796367) (← links)
- A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil (Q26796445) (← links)
- Udenafil for the treatment of erectile dysfunction (Q26851999) (← links)
- The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo (Q26863732) (← links)
- Phosphodiesterase type 5 inhibitors for the treatment of post-nerve sparing radical prostatectomy erectile dysfunction in men. (Q27687631) (← links)
- Comparison of High, Intermediate, and Low Frequency Shock Wave Lithotripsy for Urinary Tract Stone Disease: Systematic Review and Network Meta-Analysis (Q30378371) (← links)
- Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature (Q33632138) (← links)
- A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction (Q33661432) (← links)
- Intraoperative and postoperative feasibility and safety of total tubeless, tubeless, small-bore tube, and standard percutaneous nephrolithotomy: a systematic review and network meta-analysis of 16 randomized controlled trials. (Q33846224) (← links)
- Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease (Q33859035) (← links)
- Avanafil for erectile dysfunction (Q34039001) (← links)
- Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets (Q34765802) (← links)
- An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy (Q34927979) (← links)
- A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction. (Q35628328) (← links)
- Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Network Meta-analysis (Q35689075) (← links)
- Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities (Q35840149) (← links)
- Effect of sildenafil on erectile dysfunction and improvement in the quality of sexual life in China: a multi-center study. (Q36046815) (← links)
- Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain (Q37064024) (← links)
- Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. (Q37398972) (← links)
- An Empirical vs Risk-Based Approach Algorithm to Intracavernosal Injection Therapy: A Prospective Study (Q37636060) (← links)
- Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility (Q38248275) (← links)
- Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy (Q38356574) (← links)
- Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons (Q38630414) (← links)
- Neuroprotective and Nerve Regenerative Approaches for Treatment of Erectile Dysfunction after Cavernous Nerve Injury (Q38640386) (← links)
- The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction (Q38692296) (← links)
- Efficacy and safety of phosphodiesterase type 5 inhibitors on primary premature ejaculation in men receiving selective serotonin reuptake inhibitors therapy: a systematic review and meta-analysis (Q38704668) (← links)
- Avanafil - a further step to tailoring patient needs and expectations (Q38846047) (← links)
- Avanafil for the treatment of erectile dysfunction (Q38896836) (← links)
- Mean platelet volume, platelet distribution width and platelet count in erectile dysfunction: A systematic review and meta-analysis (Q38921780) (← links)
- Time of onset of vardenafil orodispersible tablet in a real-life setting - looking beyond randomized clinical trials. (Q38994942) (← links)
- When "Chems" Meet Sex: A Rising Phenomenon Called "ChemSex". (Q39010900) (← links)
- A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (Q39208990) (← links)
- The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality. (Q39406932) (← links)
- Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis (Q39456281) (← links)
- Erectile Function Predicts Sexual Satisfaction in Men With Spinal Cord Injury (Q40077467) (← links)
- Association Between Dosage Frequency and the Treatment Outcomes of Sildenafil in Young and Middle-aged Men With Erectile Dysfunction: A Chinese, Multicenter, Observational Study (Q40769021) (← links)
- Diagnostic value of four-dimensional CT angiography in arterial erectile dysfunction using 320-detector row dynamic volume CT. (Q41464324) (← links)
- The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up (Q41978840) (← links)
- From Age-Related Cognitive Decline to Alzheimer's Disease: A Translational Overview of the Potential Role for Phosphodiesterases (Q47611446) (← links)
- American Cancer Society prostate cancer survivorship care guidelines. (Q48073617) (← links)
- Erectile dysfunction and phosphodiesterase type 5 inhibitor use: associations with sexual activities, function and satisfaction in a population sample of older men. (Q48262576) (← links)
- Effects of taking tadalafil 5 mg once daily on erectile function and total testosterone levels in patients with metabolic syndrome. (Q48682809) (← links)
- Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study (Q49564612) (← links)
- Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails (Q49720693) (← links)
- [Avanafil for the treatment of erectile dysfunction in practice. Non-interventional study AVANTI]. (Q52837854) (← links)
- Effects of tadalafil treatment combined with physical activity in patients with low onset hypogonadism: results from a not-randomized single arm phase 2 study. (Q53105584) (← links)
- Relationship between Response to PDE5 Inhibitors and Penile Duplex Doppler Ultrasound in Erectile Dysfunction. (Q55413053) (← links)
- Erectile dysfunction (Q56966121) (← links)